These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13789521)

  • 1. [On serum and heparin antithrombin].
    JANUSZKO T
    Postepy Hig Med Dosw; 1961; 15():297-312. PubMed ID: 13789521
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON THROMBIN INACTIVATION IN NORMAL PLASMA, SERUM AND PLASMA FRACTIONS, AND ITS RELATION TO HEPARIN.
    BLOMBAECK B; BLOMBAECK M; OLSSON P
    Thromb Diath Haemorrh; 1963 Jul; 143():368-86. PubMed ID: 14081260
    [No Abstract]   [Full Text] [Related]  

  • 3. [A HEPARIN-TYPE ANTITHROMBIN IN A GAMMA-MYELOMA. CONSIDERATIONS ON SPONTANEOUS ANTICOAGULANTS IN KAHLER'S DISEASE].
    FAVRE-GILLY J; CREYSSEL R; THOUVEREZ JP; REVOL L; CROIZAT P
    Hemostase; 1963; 3():325-33. PubMed ID: 14151020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
    MARRAZZA P; DI GIROLAMO L
    Arch Sci Med (Torino); 1952 Jan; 93(1):9-16. PubMed ID: 14944438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with venogal, a substance in vitro; the effect on the thrombelastogram, plasmathromboplastin, plasma-antithrombin and the heparin tolerance test].
    KELLER M
    Gynaecologia; 1955 Dec; 140(6):387-92. PubMed ID: 13294645
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide.
    MONKHOUSE FC; FRANCE ES; SEEGERS WH
    Circ Res; 1955 Jul; 3(4):397-402. PubMed ID: 14390722
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.
    Byrnes JW; Swearingen CJ; Prodhan P; Fiser R; Dyamenahalli U
    ASAIO J; 2014; 60(1):57-62. PubMed ID: 24296776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies upon the relation between plasma antithrombin and heparin; influence of plasma antithrombin on prothrombin time.
    TANTURI CA; WETZEL NC
    Am J Med Sci; 1949 Apr; 217(4):410-20. PubMed ID: 18115156
    [No Abstract]   [Full Text] [Related]  

  • 9. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin and heparin in human blood.
    LOOMIS TA
    J Lab Clin Med; 1949 May; 34(5):631-6. PubMed ID: 18127770
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmatic cofactor of heparin and its relations with antithrombin].
    LOEB J
    Arch Sci Physiol (Paris); 1956; 10(2):129-42. PubMed ID: 13341284
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparin and antithrombin consumption].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1956 Jan; 104(3-4):435-44. PubMed ID: 13314711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antithrombin and heparin].
    NOLF P
    Arch Int Physiol; 1951 Feb; 58(4):441-4. PubMed ID: 14811565
    [No Abstract]   [Full Text] [Related]  

  • 15. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
    EGEBERG O
    Thromb Diath Haemorrh; 1965 Jun; 13():516-30. PubMed ID: 14347873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of heparin as antithrombin and dynamics of fibrin formation].
    AMANN R; WERLE E
    Klin Wochenschr; 1957 Jan; 35(1):22-6. PubMed ID: 13417492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Titration of heparin antithrombin with the method of gradual dilutions].
    PANELLA I; PERRINI F; BRUNO L
    Boll Soc Ital Biol Sper; 1952 Feb; 28(2):204-6. PubMed ID: 12978030
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 19. ANTITHROMBIN ACTIVITY (HEPARIN CO-FACTOR) IN PLASMA AFTER MAJOR SURGERY IN HEPARINIZED PATIENTS.
    OLSSON P; VON FRANCKEN ; NORDSTROEM S
    Acta Chir Scand; 1964 Jun; 127():578-83. PubMed ID: 14175132
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural requirements for the interaction of heparin with antithrombin III.
    Riensenfeld J; Höök M; Björk I; Lindahl U; Ajaxon B
    Fed Proc; 1977 Jan; 36(1):39-43. PubMed ID: 63389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.